Inflammation plays a critical role in coronary artery disease. In the present study, Taiwanese research departments, therefore, investigated whether L-carnitine supplementation is able to reduce inflammation in patients with this disease. 23 (out of 47) participants were assigned to a test group that received an L-Carnitine supplement (1000 mg/day) for 12 weeks. The other 24 patients were assigned to a placebo group. After supplementation with L-carnitine, the participants showed significantly reduced levels of the inflammatory markers CRP, IL-6, and TNF-α compared to measurements before supplementation – and compared to the levels in the placebo group. These results indicate that L-carnitine supplementation, due to its antioxidant effects, may be helpful in the treatment of coronary artery disease. Further details can be found in the study.


Lee et al.


Link to article >>